slides · global inventory
Diagram
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 23,622
Current window 17,311-17,340
Pages 788
Rows per page 30
Component
17,311-17,340 of 23,622
20
The diagram uses a hub-and-spoke model to position 'a.k.a.' at the center of its partner ecosystem.a.k.a. Brands | Investor Presentation Deck | 21 slides · a.k.a. Brands
Pitch deck Investor relations Beat · Team1 hit
04
The slide uses a hub-and-spoke diagram to connect Boron to four therapeutic areas (Oncology, Inflammatory Response, Parasites, Bacterial Diseases).AN2 Therapeutics | Investor Presentation Deck | 36 slides · AN2 Therapeutics
Pitch deck Investor relations Beat · Solution1 hit
09
Includes clinical trial timeline diagram and outcome tables.AN2 Therapeutics | Investor Presentation Deck | 36 slides · AN2 Therapeutics
Pitch deck Investor relations Beat · Market Size1 hit
19
The slide uses a central hub-and-spoke style diagram to connect funding sources with market potential.AN2 Therapeutics | Investor Presentation Deck | 36 slides · AN2 Therapeutics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
23
Includes a disease progression timeline diagram on the right.AN2 Therapeutics | Investor Presentation Deck | 36 slides · AN2 Therapeutics
Pitch deck Investor relations 1 hit
24
The slide uses a hub-and-spoke diagram to show the global burden relative to specific regions.AN2 Therapeutics | Investor Presentation Deck | 36 slides · AN2 Therapeutics
Pitch deck Investor relations 1 hit
29
AN2 Therapeutics | Investor Presentation Deck | 36 slidesAN2 Therapeutics | Investor Presentation Deck | 36 slides · AN2 Therapeutics
Pitch deck Investor relations 1 hit
31
The slide uses a hub-and-spoke diagram to connect Boron to various medical fields, with a specific callout to oncology applications.AN2 Therapeutics | Investor Presentation Deck | 36 slides · AN2 Therapeutics
Pitch deck Investor relations 1 hit
32
The slide uses a hub-and-spoke diagram to connect the central Boron element to four therapeutic areas, then links to specific development programs.AN2 Therapeutics | Investor Presentation Deck | 36 slides · AN2 Therapeutics
Pitch deck Investor relations 1 hit
17
The slide highlights specific clinical trial names and their associated indications, with a focus on the camizestrant program.AstraZeneca | Results Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · VisualizationLoop · Golden Circle1 hit
04
Uses a Venn diagram to illustrate the strategic positioning of the company's pipeline.Cipher Mining | Investor Presentation Deck | 26 slides · Cipher Mining
Pitch deck Investor relations Beat · What Is1 hit
07
The slide uses a waterfall chart to bridge 2024 reported RoTE to the 2025 target.Deutsche Bank | Results Presentation Deck | 54 slides · Deutsche Bank
Conference presentation Investor relations Beat · SatisfactionLoop · Golden Circle1 hit
07
Uses a value-chain style diagram to show the flow between carriers, forwarders, and shippers.Freightos | Investor Presentation Deck | 39 slides · Freightos
Pitch deck Investor relations Beat · NeedLoop · Pattern Hunter1 hit
10
Uses a 'passenger travel' analogy to explain the freight booking market structure.Freightos | Investor Presentation Deck | 39 slides · Freightos
Pitch deck Investor relations Beat · SatisfactionLoop · Golden Circle1 hit
15
The timeline uses a split-level design to show events occurring above and below the central axis.HBT Financial | Results Presentation Deck | 36 slides · HBT Financial
Conference presentation Investor relations 1 hit
17
Uses a process-style arrow diagram to represent strategic pillars.HBT Financial | Results Presentation Deck | 36 slides · HBT Financial
Conference presentation Investor relations 1 hit
26
The slide uses a horizontal timeline with alternating top and bottom callouts for acquisition events.HBT Financial | Results Presentation Deck | 36 slides · HBT Financial
Conference presentation Investor relations 1 hit
10
Uses a process flow diagram to illustrate the biological mechanism from receptor activation to clinical outcome.MindMed | Investor Presentation Deck | 28 slides · MindMed
Pitch deck Investor relations 1 hit
18
The slide outlines a two-part study design (Part A: Randomized/Double-Blind, Part B: Open-Label Extension) with specific patient counts and dosing regimens.MindMed | Investor Presentation Deck | 28 slides · MindMed
Pitch deck Investor relations 1 hit
19
The slide outlines two study arms (MM120 ODT 100 µg and Placebo) with a primary endpoint at week 6, followed by a 40-week extension.MindMed | Investor Presentation Deck | 28 slides · MindMed
Pitch deck Investor relations 1 hit
20
The slide uses a linked-circle diagram to represent a sequence or interconnected set of regulatory requirements.MindMed | Investor Presentation Deck | 28 slides · MindMed
Pitch deck Investor relations 1 hit
23
The 'Quadruple Aim' is a well-known healthcare framework. The visual is a quadrant diagram.MindMed | Investor Presentation Deck | 28 slides · MindMed
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
27
The slide outlines two parallel studies (Voyage and Panorama) with specific participant counts and dosing regimens.MindMed | Investor Presentation Deck | 28 slides · MindMed
Pitch deck Investor relations 1 hit
20
Shows a process flow between follow-up observation and potential treatment based on clinical criteria.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
21
Includes logos for Voyage and Panorama studies; references statistical power assumptions in footnotes.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
25
The slide outlines a clinical trial protocol with a primary endpoint at week 6 and a 40-week extension phase.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
26
Includes study timeline, randomization details, entry criteria, and secondary endpoints.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
29
Includes study arms, dosing, follow-up timeline, entry criteria, and secondary endpoints.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
31
The slide uses a CONSORT-style flow diagram to track patient retention.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
08
The diagram uses a flywheel/network effect structure to show how different stakeholders interact with the central platform.Nextdoor | Investor Presentation Deck | 36 slides · Nextdoor
Pitch deck Investor relations Beat · Solution1 hit